Dan Gallagher

Dan Gallagher has extensive experience in business development, with a focus on the pharmaceutical and clinical research industries. Dan currently holds the position of Head of Business Development North America and Europe at George Clinical since January 2024. Prior to this, they worked as Vice President of Business Development at Vial from October 2022 to December 2023.

From 2016 to 2022, Dan served at IQVIA, where they held various roles including Senior Director and Director of Global Business Development within the dermatology-focused division. At TKL Research, they briefly worked as Director of Business Development in 2016, specializing in dermatology clinical trials.

Before entering the healthcare industry, Dan gained experience in sales and management roles. Dan worked as Associate Account Director and Sr. Account Development Representative at PPD from 2011 to 2016, engaging with pharmaceutical and biotech sponsors to support their drug development programs. Prior to PPD, they served in sales positions at WHI and MarineMax Inc, where they honed their skills in operations management and sales.

Dan began their career in sales at Time Warner Cable in 2003. Overall, they have a strong background in business development, clinical research, and sales, with a particular focus on the pharmaceutical and dermatology sectors.

Dan Gallagher's education history includes a Master of Business Administration (M.B.A.) degree in Business Administration and Management from the University of North Carolina Wilmington, completed from 2012 to 2014. Dan also pursued Clinical Research Graduate Study in Issues in Global Regulatory Development and Management from the same university in 2014. Dan Gallagher received Continuing Education in Clinical Research Overview from Cape Fear Community College in 2011. Furthermore, they obtained a Bachelor's degree in Business Management from the University of North Carolina Wilmington's Cameron School of Business from 1999 to 2002.